BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6271584)

  • 1. Effect of indomethacin on the binding of the chemotactic peptide formyl-Met-Leu-Phe on human polymorphonuclear leukocytes.
    Cost H; Gespach C; Abita JP
    FEBS Lett; 1981 Sep; 132(1):85-8. PubMed ID: 6271584
    [No Abstract]   [Full Text] [Related]  

  • 2. Indomethacin is a competitive inhibitor of the binding of the chemotactic peptide formyl-Met-Leu-Phe to human polymorphonuclear leukocytes.
    Abita JP
    Agents Actions; 1981 Dec; 11(6-7):610-2. PubMed ID: 6803537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of granulocyte response to the chemoattractant F-Met-Leu-Phe.
    Dahlgren C; Stendahl O
    Adv Exp Med Biol; 1982; 155():107-12. PubMed ID: 6297266
    [No Abstract]   [Full Text] [Related]  

  • 4. Adaptation of human neutrophil responsiveness to the chemoattractant N-formylmethionylleucylphenylalanine. Heterogeneity and/or negative cooperative interaction of receptors.
    Seligmann BE; Fletcher MP; Gallin JI
    J Biol Chem; 1982 Jun; 257(11):6280-6. PubMed ID: 6281264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of polymorphonuclear leukocyte chemiluminescent response to the chemoattractant f-Met-Leu-Phe.
    Dahlgren C; Magnusson KE; Stendahl O; Sundqvist T
    Int Arch Allergy Appl Immunol; 1982; 68(1):79-83. PubMed ID: 6281196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
    Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
    J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Showell HJ; Freer RJ; Becker EL
    J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers.
    Yuli I; Tomonaga A; Synderman R
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5906-10. PubMed ID: 6310554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotactic receptor of cord blood granulocytes to the synthesized chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Nunoi H; Endo F; Chikazawa S; Namikawa T; Matsuda I
    Pediatr Res; 1983 Jan; 17(1):57-60. PubMed ID: 6300743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5,8,11,14-Eicosatetraynoic acid (ETYA) inhibits binding of N-formyl-methionyl-leucyl-phenylalanine (FLMP) to its receptor on human granulocytes. A note of caution.
    Atkinson JP; Simchowitz L; Mehta J; Stenson WF
    Immunopharmacology; 1982 Feb; 4(1):1-9. PubMed ID: 6277829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human neutrophils contain an intracellular pool of putative receptors for the chemoattractant N-formyl-methionyl-leucyl-phenylalanine.
    Fletcher MP; Gallin JI
    Blood; 1983 Oct; 62(4):792-9. PubMed ID: 6309284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actin polymerization induced by chemotactic peptide and concanavalin A in rat neutrophils.
    Rao KM; Varani J
    J Immunol; 1982 Oct; 129(4):1605-7. PubMed ID: 6286771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthetic chemotactic peptide formyl-methionyl-leucyl-phenylalanine causes an increase in actin associated with the cytoskeleton in rabbit neutrophils.
    White JR; Naccache PH; Sha'afi RI
    Biochem Biophys Res Commun; 1982 Oct; 108(3):1144-9. PubMed ID: 6891213
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
    Beswick PH; Kay AB
    Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone synergistically induces chemotactic peptide receptor expression in HL-60 cells.
    Skubitz KM; Zhen YS; August JT
    Blood; 1982 Mar; 59(3):586-93. PubMed ID: 6277411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deactivation of the effects of F-Met-Leu-Phe and leukotriene B4 on calcium mobilization in rabbit neutrophils.
    Sha'afi RI; Molski TF; Borgeat P; Naccache PH
    Biochem Biophys Res Commun; 1981 Nov; 103(2):766-73. PubMed ID: 6277317
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamics of human neutrophil receptors for the chemoattractant fmet-leu-phe.
    Gallin JI; Seligmann BE; Fletcher MP
    Agents Actions Suppl; 1983; 12():290-308. PubMed ID: 6301232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes.
    Lohr KM; Snyderman R
    J Immunol; 1982 Oct; 129(4):1594-9. PubMed ID: 6286769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of granulocyte adhesiveness by the chemotactic peptide N-formyl-L-methionyl-L-phenylalanine.
    Patrone F; Dallegri F; Sacchetti C
    Res Exp Med (Berl); 1980; 177(1):19-22. PubMed ID: 7403684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonists of the formylated peptide chemoattractants: structure-activity comparisons with formyl-methionyl-leucyl-phenylalanine-OH.
    Freer RJ; Day AR; Muthukumaraswamy N; Showell HJ; Becker EL
    Kroc Found Ser; 1981; 14():161-8. PubMed ID: 6947071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.